SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,487,547 | -33.2% | 65,382 | -19.7% | 0.27% | +5.0% |
Q1 2023 | $11,217,019 | +0.7% | 81,383 | -5.3% | 0.26% | +35.9% |
Q4 2022 | $11,138,049 | +1.3% | 85,955 | -13.6% | 0.19% | +2.7% |
Q3 2022 | $10,996,000 | +171.4% | 99,477 | +91.8% | 0.19% | +136.7% |
Q1 2022 | $4,051,000 | -8.2% | 51,860 | +5.8% | 0.08% | -31.9% |
Q4 2021 | $4,413,000 | +7.7% | 49,009 | +10.6% | 0.12% | +54.7% |
Q3 2021 | $4,098,000 | +62.7% | 44,309 | +31.1% | 0.08% | +74.4% |
Q1 2021 | $2,519,000 | – | 33,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |